Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Cash Flow 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||
| Operating Cash Flow | 4.98B | 4.42B | 4.59B | 5.01B | 7.08B | 2.62B | 2.43B | 2.20B | 1.31B | 1.49B | 1.33B | 752.4M | 588.6M | -74.6M | -141.7M | 99.2M | -69.9M | -89.1M |
| Depreciation & Amort. | 543.7M | 482.9M | 421.0M | 341.4M | 286.2M | 235.9M | 210.3M | 148.2M | 145.5M | 104.7M | 74.9M | 52.7M | 41.2M | 36.9M | 31.1M | 19.7M | 14.2M | 11.3M |
| Investing Activities | ||||||||||||||||||
| Capital Expenditure | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||||||||||||
| Dividends Paid | 370.3M | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 3.44B | 2.60B | 2.23B | 2.08B | 1.65B | 5.85B | 275.9M | 4.4M | 0 | 0 | — | — | — | — | — | — | — | — |
Regeneron Pharmaceuticals Inc. Cash Flow — FAQ
Regeneron Pharmaceuticals Inc. (REGN) cash flow over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's cash flow history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s cash flow by year and by quarter, including the growth rate.